Literature DB >> 19103149

Human tissue factor pathway inhibitor-2 is internalized by cells and translocated to the nucleus by the importin system.

Prakasha Kempaiah1, Hitendra S Chand, Walter Kisiel.   

Abstract

Tissue factor pathway inhibitor-2 (TFPI-2) is a serine proteinase inhibitor that induces caspase-mediated apoptosis when offered to a variety of tumor cells. In order to investigate the mechanism of TFPI-2-induced apoptosis, we initially studied the uptake and trafficking of TFPI-2 by HT-1080 cells. Exogenously offered TFPI-2 was rapidly internalized and distributed in both the cytosolic and nuclear fractions. Nuclear localization of TFPI-2 was also detected in a variety of endothelial cells constitutively expressing TFPI-2. Nuclear localization of TFPI-2 required a NLS sequence located in its Lys/Arg-rich C-terminal tail comprising residues 191-211, as a TFPI-2 construct lacking the C-terminal tail failed to localize to the nucleus. Complexes of TFPI-2 and importin-alpha were co-immunoprecipitated from cell lysates of HT-1080 cells either offered or overexpressing this protein, providing evidence that TFPI-2 was shuttled to the nucleus by the importin system. Our results provide the initial description of TFPI-2 internalization and translocation to the nucleus in a number of cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19103149      PMCID: PMC2666392          DOI: 10.1016/j.abb.2008.11.028

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  33 in total

1.  Characterization of a class of cationic peptides able to facilitate efficient protein transduction in vitro and in vivo.

Authors:  Z Mi; J Mai; X Lu; P D Robbins
Journal:  Mol Ther       Date:  2000-10       Impact factor: 11.454

2.  Localization of a serine proteinase inhibitor, B-43, in the bovine pancreas.

Authors:  M Nishibori; N Nakaya; A Ohtsuka; T Murakami; K Saeki
Journal:  Histochem Cell Biol       Date:  1998-07       Impact factor: 4.304

3.  Degradation of DNA topoisomerase I by a novel trypsin-like serine protease in proliferating human T lymphocytes.

Authors:  H J Chen; C L Hwong; C H Wang; J Hwang
Journal:  J Biol Chem       Date:  2000-04-28       Impact factor: 5.157

4.  Characterization of a murine monoclonal antibody that mimics heparin-induced thrombocytopenia antibodies.

Authors:  G M Arepally; S Kamei; K S Park; K Kamei; Z Q Li; W Liu; D L Siegel; W Kisiel; D B Cines; M Poncz
Journal:  Blood       Date:  2000-03-01       Impact factor: 22.113

5.  The third helix of the Antennapedia homeodomain translocates through biological membranes.

Authors:  D Derossi; A H Joliot; G Chassaing; A Prochiantz
Journal:  J Biol Chem       Date:  1994-04-08       Impact factor: 5.157

6.  Quantification and characterization of human endothelial cell-derived tissue factor pathway inhibitor-2.

Authors:  M Iino; D C Foster; W Kisiel
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-01       Impact factor: 8.311

7.  Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis.

Authors:  M P Herman; G K Sukhova; W Kisiel; D Foster; M R Kehry; P Libby; U Schönbeck
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

8.  Partial characterization of matrix-associated serine protease inhibitors from human skin cells.

Authors:  C N Rao; C L Peavey; Y Y Liu; J C Lapiere; D T Woodley
Journal:  J Invest Dermatol       Date:  1995-03       Impact factor: 8.551

9.  Nuclear trafficking of secreted factors and cell-surface receptors: new pathways to regulate cell proliferation and differentiation, and involvement in cancers.

Authors:  Nathalie Planque
Journal:  Cell Commun Signal       Date:  2006-10-18       Impact factor: 5.712

10.  Identification of a human TFPI-2 splice variant that is upregulated in human tumor tissues.

Authors:  Prakasha Kempaiah; Hitendra S Chand; Walter Kisiel
Journal:  Mol Cancer       Date:  2007-03-12       Impact factor: 27.401

View more
  4 in total

1.  Beneficial role of overexpression of TFPI-2 on tumour progression in human small cell lung cancer.

Authors:  Marion Lavergne; Marie-Lise Jourdan; Claire Blechet; Serge Guyetant; Alain Le Pape; Nathalie Heuze-Vourc'h; Yves Courty; Stephanie Lerondel; Julien Sobilo; Sophie Iochmann; Pascale Reverdiau
Journal:  FEBS Open Bio       Date:  2013-06-27       Impact factor: 2.693

2.  Tissue factor pathway inhibitor‑2 is specifically expressed in ovarian clear cell carcinoma tissues in the nucleus, cytoplasm and extracellular matrix.

Authors:  Yukihide Ota; Shiro Koizume; Yoshiyasu Nakamura; Mitsuyo Yoshihara; Tomoko Takahashi; Shinya Sato; Shohei Myoba; Norihisa Ohtake; Hisamori Kato; Tomoyuki Yokose; Etsuko Miyagi; Yohei Miyagi
Journal:  Oncol Rep       Date:  2021-01-20       Impact factor: 3.906

3.  Localization of TFPI-2 in the nucleus modulates MMP-2 gene expression in breast cancer cells.

Authors:  Guangli Wang; Yao Zeng; Shaoying Chen; Deling Li; Wei Li; Yanchun Zhou; Robert H Singer; Wei Gu
Journal:  Sci Rep       Date:  2017-10-19       Impact factor: 4.379

4.  TFPI-2 suppresses breast cancer cell proliferation and invasion through regulation of ERK signaling and interaction with actinin-4 and myosin-9.

Authors:  Guangli Wang; Wenhe Huang; Wei Li; Shaoying Chen; Weibin Chen; Yanchun Zhou; Pei Peng; Wei Gu
Journal:  Sci Rep       Date:  2018-09-26       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.